TD Asset Management »

Alpine Immune Sciences shares owned by TD Asset Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $633k 33k 19.06

More positions owned by TD Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Canadian Pacific Kansas City (CP)
UnitedHealth (UNH)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Visa Com Cl A (V)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Eli Lilly & Co. (LLY)

View all positions for TD Asset Management

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences